Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 9
Submit an article Journal homepage
3,125
Views
3
CrossRef citations to date
0
Altmetric
Articles

Real-world healthcare resource utilization and costs associated with tisagenlecleucel and axicabtagene ciloleucel among patients with diffuse large B-cell lymphoma: an analysis of hospital data in the United States

Richard T. Maziarza Center for Hematologic Malignancies, Oregon Health and Science University, Portland, OR, USA;b Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USACorrespondence[email protected]
View further author information
,
Hongbo Yangc Analysis Group, Inc., Boston, MA, USAView further author information
,
Qing Liuc Analysis Group, Inc., Boston, MA, USAView further author information
,
Travis Wangc Analysis Group, Inc., Boston, MA, USAView further author information
,
Jing Zhaoc Analysis Group, Inc., Boston, MA, USAView further author information
,
Stephen Limd Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information
,
Soyon Leed Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAORCID Iconhttps://orcid.org/0000-0002-2059-717XView further author information
ORCID Icon,
Anand Dalald Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information
&
Vamsi Bollud Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAView further author information
 show all
Pages 2052-2062 | Received 07 Jan 2022, Accepted 22 Mar 2022, Published online: 14 Apr 2022

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Rakesh Awasthi, Harald J. Maier, Jie Zhang & Stephen Lim. (2023) Kymriah® (tisagenlecleucel) – An overview of the clinical development journey of the first approved CAR-T therapy. Human Vaccines & Immunotherapeutics 19:1.
Read now

Articles from other publishers (2)

Sérgio Chacim, Teresa Monjardino, José Luís Cunha, Pedro Medeiros, Patrícia Redondo, Maria José Bento & José Mário Mariz. (2022) Costs, effectiveness, and safety associated with Chimeric Antigen Receptor (CAR) T-cell therapy: Results from a comprehensive cancer center. PLOS ONE 17:12, pages e0278950.
Crossref
Mi Kwon, Gloria Iacoboni, Juan Luis Reguera, Lucía López Corral, Rafael Hernani Morales, Valentín Ortiz-Maldonado, Manuel Guerreiro, Ana Carolina Caballero, María Luisa Guerra Domínguez, Jose Maria Sanchez Pina, Alberto Mussetti, Juan Manuel Sancho, Mariana Bastos-Oreiro, Eva Catala, Javier Delgado, Hugo Luzardo Henriquez, Jaime Sanz, María Calbacho, Rebeca Bailén, Cecilia Carpio, Jose Maria Ribera, Anna Sureda, Javier Briones, Juan Carlos Hernandez-Boluda, Nuria Martínez Cebrián, Jose Luis Diez Martin, Alejandro Martín & Pere Barba. (2022) Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma. Haematologica 108:1, pages 110-121.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.